Avanos Medical, Inc. (AVNS)


+0.02 (+0.09%)
Symbol AVNS
Price $22.18
Beta 0.873
Volume Avg. 0.25M
Market Cap 1.031B
Shares () -
52 Week Range 21.39-36.44
1y Target Est -
DCF Unlevered AVNS DCF ->
DCF Levered AVNS LDCF ->
ROE -0.63% Neutral
ROA -0.45% Neutral
Operating Margin -
Debt / Equity 40.04% Neutral
P/E 56.87 Strong Buy
P/B 0.84 Buy


Consensus EPS

Upgrades & Downgrades

Latest AVNS news

Mr. Joseph Woody
Medical Devices
New York Stock Exchange

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.